India · Delayed Price · Currency is INR Intra-Cellular Therapies Statistics
Total Valuation
NSE:RAMCOCEM has a market cap or net worth of INR 272.00 billion. The enterprise value is 317.07 billion.
| Market Cap | 272.00B |
| Enterprise Value | 317.07B |
Important Dates
The last earnings date was Friday, August 1, 2025.
| Earnings Date | Aug 1, 2025 |
| Ex-Dividend Date | Aug 6, 2025 |
Share Statistics
NSE:RAMCOCEM has 236.29 million shares outstanding. The number of shares has increased by 3.59% in one year.
| Current Share Class | 236.29M |
| Shares Outstanding | 236.29M |
| Shares Change (YoY) | +3.59% |
| Shares Change (QoQ) | -1.27% |
| Owned by Insiders (%) | 3.34% |
| Owned by Institutions (%) | 36.69% |
| Float | 126.62M |
Valuation Ratios
The trailing PE ratio is 99.84 and the forward PE ratio is 50.00. NSE:RAMCOCEM's PEG ratio is 0.58.
| PE Ratio | 99.84 |
| Forward PE | 50.00 |
| PS Ratio | 3.19 |
| PB Ratio | 3.65 |
| P/TBV Ratio | 3.87 |
| P/FCF Ratio | 72.58 |
| P/OCF Ratio | 19.45 |
| PEG Ratio | 0.58 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 25.56, with an EV/FCF ratio of 84.61.
| EV / Earnings | 116.29 |
| EV / Sales | 3.72 |
| EV / EBITDA | 25.56 |
| EV / EBIT | 57.80 |
| EV / FCF | 84.61 |
Financial Position
The company has a current ratio of 0.52, with a Debt / Equity ratio of 0.63.
| Current Ratio | 0.52 |
| Quick Ratio | 0.24 |
| Debt / Equity | 0.63 |
| Debt / EBITDA | 3.78 |
| Debt / FCF | 12.49 |
| Interest Coverage | 1.59 |
Financial Efficiency
Return on equity (ROE) is 3.67% and return on invested capital (ROIC) is 2.81%.
| Return on Equity (ROE) | 3.67% |
| Return on Assets (ROA) | 2.10% |
| Return on Invested Capital (ROIC) | 2.81% |
| Return on Capital Employed (ROCE) | 4.55% |
| Revenue Per Employee | 22.61M |
| Profits Per Employee | 723,786 |
| Employee Count | 3,767 |
| Asset Turnover | 0.52 |
| Inventory Turnover | 3.99 |
Taxes
In the past 12 months, NSE:RAMCOCEM has paid 511.70 million in taxes.
| Income Tax | 511.70M |
| Effective Tax Rate | 15.95% |
Stock Price Statistics
The stock price has increased by +39.35% in the last 52 weeks. The beta is -0.08, so NSE:RAMCOCEM's price volatility has been lower than the market average.
| Beta (5Y) | -0.08 |
| 52-Week Price Change | +39.35% |
| 50-Day Moving Average | 1,079.56 |
| 200-Day Moving Average | 960.04 |
| Relative Strength Index (RSI) | 53.74 |
| Average Volume (20 Days) | 479,268 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:RAMCOCEM had revenue of INR 85.18 billion and earned 2.73 billion in profits. Earnings per share was 11.53.
| Revenue | 85.18B |
| Gross Profit | 45.30B |
| Operating Income | 5.47B |
| Pretax Income | 3.21B |
| Net Income | 2.73B |
| EBITDA | 12.38B |
| EBIT | 5.47B |
| Earnings Per Share (EPS) | 11.53 |
Balance Sheet
The company has 1.73 billion in cash and 46.80 billion in debt, giving a net cash position of -45.07 billion or -190.75 per share.
| Cash & Cash Equivalents | 1.73B |
| Total Debt | 46.80B |
| Net Cash | -45.07B |
| Net Cash Per Share | -190.75 |
| Equity (Book Value) | 74.42B |
| Book Value Per Share | 314.93 |
| Working Capital | -20.75B |
Cash Flow
In the last 12 months, operating cash flow was 13.99 billion and capital expenditures -10.24 billion, giving a free cash flow of 3.75 billion.
| Operating Cash Flow | 13.99B |
| Capital Expenditures | -10.24B |
| Free Cash Flow | 3.75B |
| FCF Per Share | 15.86 |
Margins
Gross margin is 53.17%, with operating and profit margins of 6.42% and 3.20%.
| Gross Margin | 53.17% |
| Operating Margin | 6.42% |
| Pretax Margin | 3.77% |
| Profit Margin | 3.20% |
| EBITDA Margin | 14.53% |
| EBIT Margin | 6.42% |
| FCF Margin | 4.40% |
Dividends & Yields
This stock pays an annual dividend of 2.00, which amounts to a dividend yield of 0.17%.
| Dividend Per Share | 2.00 |
| Dividend Yield | 0.17% |
| Dividend Growth (YoY) | -20.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 21.69% |
| Buyback Yield | -3.59% |
| Shareholder Yield | -3.42% |
| Earnings Yield | 1.00% |
| FCF Yield | 1.38% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on October 1, 2008. It was a forward split with a ratio of 20.
| Last Split Date | Oct 1, 2008 |
| Split Type | Forward |
| Split Ratio | 20 |
Scores
NSE:RAMCOCEM has an Altman Z-Score of 2.48 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.48 |
| Piotroski F-Score | 6 |